Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03329001 |
| Title | Crossover Study to Assess the Relative Bioavailability of Niraparib Tablet Compared to Niraparib Capsule |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Tesaro, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Encinitas | California | 92024 | United States | Details | |
| GSK Investigational Site | Fresno | California | 93720 | United States | Details | |
| GSK Investigational Site | Denver | Colorado | 80218 | United States | Details | |
| GSK Investigational Site | New Haven | Connecticut | 06520 | United States | Details | |
| GSK Investigational Site | Sarasota | Florida | 34232 | United States | Details | |
| GSK Investigational Site | Atlanta | Georgia | 30322 | United States | Details | |
| GSK Investigational Site | Grand Rapids | Michigan | 49546 | United States | Details | |
| GSK Investigational Site | Jackson | Mississippi | 39216 | United States | Details | |
| GSK Investigational Site | Cincinnati | Ohio | 45267 | United States | Details | |
| GSK Investigational Site | Cleveland | Ohio | 44106 | United States | Details | |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
| GSK Investigational Site | Dallas | Texas | 75230 | United States | Details | |
| GSK Investigational Site | Houston | Texas | 77030 | United States | Details | |
| GSK Investigational Site | San Antonio | Texas | 78229 | United States | Details | |
| GSK Investigational Site | San Marcos | Texas | 92069 | United States | Details |